Mescaline

DB19083InvestigationalSmall molecule

Mescaline is under investigation in clinical trial NCT05933213 (Comparing Mescaline Sodium Enteric-coated Tablets vs Morte-mescaline in the Treatment of Adult Lupus Nephritis).

Formula / weight: C₁₁H₁₇NO₃ · 211.261 g/mol (avg)
Also known as: 2-(3,4,5-trimethoxyphenyl)ethanamine · 3,4,5-trimethoxyphenethylamine
Code names: NSC-30419

Resolves to

Compound

UNIIRHO99102VCCAS54-04-6ChEMBLCHEMBL26687ChEBI28346KEGGC06546

Structure

InChIKeyRHCSKNNOAZULRK-UHFFFAOYSA-NSMILESCOC1=CC(CCN)=CC(OC)=C1OC

Targets

P28223HTR2A

What you can answer from here — as of January 29, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

2Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Mescaline, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account